Serial biopharma founder seeks to transform an Alzheimer's drug into an autism therapy
September 28, 2020 at 14:59 PM EDT
For years, hundreds of thousands of Alzheimer’s or dementia patients like local entrepreneur Mark Tepper’s late mother have relied on a drug with a modest benefit. Tepper thinks his new company can broaden its impact.